組織工学に基づく皮膚代替物市場：製品（生物学的、生合成、合成）、用途（急性創傷、慢性創傷）、最終用途別-2023-2030年の世界予測

組織工学に基づく皮膚代替物の世界市場は大きく成長すると予測され、2023年には11億2,075万米ドルが予測され、CAGRは12.58%、2030年には25億8,058万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の組織工学に基づく皮膚代替物市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.組織工学に基づく皮膚代替物の世界市場規模および予測は？

2.予測期間中、世界の組織工学に基づく皮膚代替物市場を形成するCOVID-19の阻害要因と影響は？

3.組織工学に基づく皮膚代替物の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.組織工学に基づく皮膚代替物の世界市場における競争戦略は？

5.組織工学に基づく皮膚代替物の世界市場における技術動向と規制の枠組みは？

6.組織工学に基づく皮膚代替物の世界市場における主要ベンダーの市場シェアは？

7.組織工学に基づく皮膚代替物の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 急性および慢性創傷の有病率の上昇
    • 皮膚移植の需要の増加
    • 皮膚再生技術の進歩
  • 抑制要因
    • 皮膚付属器を再生する能力が限られている
  • 機会
    • ヘルスケアにおける技術の進歩と研究開発投資
    • 市場への普及を促進し、拡大するための官民連携
  • 課題
    • 支援的な償還ポリシーの欠如
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 組織工学に基づく皮膚代替物市場：製品別

• 生物学的
• 生合成
• 合成

第7章 組織工学に基づく皮膚代替物市場：用途別

• 急性の傷
  • 火傷
  • 手術と外傷
• 慢性の傷
  • 糖尿病性足潰瘍
  • その他の慢性創傷
  • 褥瘡
  • 静脈性脚潰瘍

第8章 組織工学に基づく皮膚代替物市場：最終用途別

• 病院
• 創傷ケアセンター

第9章 南北アメリカの組織工学に基づく皮膚代替物市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の組織工学に基づく皮膚代替物市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの組織工学に基づく皮膚代替物市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET RESEARCH PROCESS
• FIGURE 2. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2022 VS 2030
• FIGURE 3. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2022 VS 2030 (%)
• FIGURE 7. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET DYNAMICS
• FIGURE 9. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOSYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 9. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 10. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BURN INJURIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SURGERY & TRAUMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 14. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY OTHER CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY VENOUS LEG ULCERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 20. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY WOUND CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 41. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 65. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 68. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 70. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 73. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 95. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 100. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 105. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 110. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 115. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 120. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 126. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 131. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 136. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 141. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 146. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 151. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 156. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 159. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 161. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 166. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 171. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 176. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 179. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 181. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 184. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 186. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 191. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 196. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 201. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 206. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 211. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 216. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 221. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
• TABLE 231. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 232. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 233. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET LICENSE & PRICING

The Global Tissue Engineered Skin Substitutes Market is forecasted to grow significantly, with a projected USD 1,120.75 million in 2023 at a CAGR of 12.58% and expected to reach a staggering USD 2,580.58 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Tissue Engineered Skin Substitutes Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Tissue Engineered Skin Substitutes Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biological, Biosynthetic, and Synthetic. The Biological is projected to witness significant market share during forecast period.

Based on Application, market is studied across Acute Wounds and Chronic Wounds. The Acute Wounds is further studied across Burn Injuries and Surgery & Trauma. The Chronic Wounds is further studied across Diabetic Foot Ulcers, Other Chronic Wounds, Pressure Ulcers, and Venous Leg Ulcers. The Chronic Wounds is projected to witness significant market share during forecast period.

Based on End Use, market is studied across Hospitals and Wound Care Centers. The Wound Care Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Tissue Engineered Skin Substitutes Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Tissue Engineered Skin Substitutes Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Engineered Skin Substitutes Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Engineered Skin Substitutes Market?

4. What is the competitive strategic window for opportunities in the Global Tissue Engineered Skin Substitutes Market?

5. What are the technology trends and regulatory frameworks in the Global Tissue Engineered Skin Substitutes Market?

6. What is the market share of the leading vendors in the Global Tissue Engineered Skin Substitutes Market?

7. What modes and strategic moves are considered suitable for entering the Global Tissue Engineered Skin Substitutes Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Tissue Engineered Skin Substitutes Market, by Product, 2022 vs 2030
• 4.3. Tissue Engineered Skin Substitutes Market, by Application, 2022 vs 2030
• 4.4. Tissue Engineered Skin Substitutes Market, by End Use, 2022 vs 2030
• 4.5. Tissue Engineered Skin Substitutes Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of acute and chronic wounds
    • 5.1.1.2. Increased demand for skin grafts
    • 5.1.1.3. Advances in skin regeneration technology
  • 5.1.2. Restraints
    • 5.1.2.1. Limited ability to reproduce skin appendages
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and R&D investment in healthcare
    • 5.1.3.2. Public-private alliance to promote and increase penetration in market
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of supportive reimbursement policies
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Tissue Engineered Skin Substitutes Market, by Product

• 6.1. Introduction
• 6.2. Biological
• 6.3. Biosynthetic
• 6.4. Synthetic

7. Tissue Engineered Skin Substitutes Market, by Application

• 7.1. Introduction
• 7.2. Acute Wounds
  • 7.2.1. Burn Injuries
  • 7.2.2. Surgery & Trauma
• 7.3. Chronic Wounds
  • 7.3.1. Diabetic Foot Ulcers
  • 7.3.2. Other Chronic Wounds
  • 7.3.3. Pressure Ulcers
  • 7.3.4. Venous Leg Ulcers

8. Tissue Engineered Skin Substitutes Market, by End Use

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Wound Care Centers

9. Americas Tissue Engineered Skin Substitutes Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Tissue Engineered Skin Substitutes Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Engineered Skin Substitutes Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing